Form EFFECT Clearside Biomedical,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 16, 2025 |
| Accession Number: | 0001193125-25-319161 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worldline positioned as a Leader in the 2026 SPARK Matrix™ for Merchant Payment Platform by QKS Group
- Global Times: Saudi Arabia's first cultural counselor to China tells youth to seize 'golden opportunities' in bilateral ties
- Form 8.5 (EPT/RI) - Kore Potash Plc
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share